![Tony Yu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 676 469 $ al 31/08/2026
Tony Yu currently holds the position of Chief Scientific Officer at Genelux Corp.
since 2026 and is a Member of the American Society of Clinical Oncology, Inc. Education history includes an undergraduate degree from the University of Utah and a doctorate from Loma Linda University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GENELUX CORP. 0,57 % | 31/08/2026 | 258.688 ( 0,57 % ) | 676 469 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GENELUX CORPORATION | Director Técnico/Científico/I+D | 01/05/2026 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Genelux Corp.
 Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loma Linda University
 Loma Linda University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
